Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment
Ottawa Hospital Research Institute
· 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
primary immunodeficiency disease, secondary immunodeficiency, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Artegraft Versus Propaten Dialysis Grafts
#1010993
Epilepsy Self-Management for Spanish Speakers: HOBSCOTCH - ESPANOL
#1010984
Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.
#1010985
Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer
#1010986
Comparison of Spinal Stabilization Exercises Vs Maitland Mobilization Along With Laser Therapy
#1010989
Record
· ID 992781
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.